Efficacy and tolerability of linezolid in chronic osteomyelitis and prosthetic joint infections: A case-control study

Journal of Chemotherapy

Volumn 21, Issue 2, 2009, Pages 165-169

  Papadopoulos, A ^a   Plachouras, D ^a   Giannitsioti, E ^a   Poulakou, G ^a   Giamarellou, H ^a   Kanellakopoulou, K ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Bone infection; Linezolid; MRSA

Indexed keywords

LINEZOLID;

ADULT; AGED; ANEMIA; ARTICLE; BLEEDING; BLOOD TOXICITY; CASE CONTROL STUDY; CHRONIC OSTEOMYELITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; JOINT PROSTHESIS; MALE; MONITORING; OPTIC NERVE DISEASE; PERIPHERAL NEUROPATHY; PROSTHESIS INFECTION; THROMBOCYTOPENIA; TREATMENT WITHDRAWAL;

EID: 67449089300     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2009.21.2.165     Document Type: Article

References (22)

1. Moellering RC, Jr. Linezolid: the first oxazolidinone antimicrobial. Ann Intern Med 2003; 138(2): 135-142.
2. French G. Safety and tolerability of linezolid. J Antimicrob Chemother 2003; 51(90002): 45ii-53.
3. Gerson SL, Kaplan SL, Bruss JB, Le V, Arellano FM, Hafkin B et al. Hematologic effects of linezolid: summary of clinical experience. Antimicrob Agents Chemother 2002; 46(8): 2723-2726.
4. Lee E, Burger S, Shah J, Melton C, Mullen M, Warren F et al. Linezolid-associated toxic optic neuropathy: a report of 2 cases. Clin Infect Dis 2003; 37(10): 1389-1391.
5. Lew DP, Waldvogel FA. Osteomyelitis. Lancet 2004; 364(9431): 369-379.
6. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-Joint infections. N Engl J Med 2004; 351(16): 1645-1654.
7. Calhoun JH, Manring MM. Adult osteomyelitis. Infect Dis Clin N Amer 2005; 19(4): 765-786.
8. Velasco D, del Mar TM, Cartelle M, Beceiro A, Perez A, Molina F et al. Evaluation of different methods for detecting me-thicillin (oxacillin) resistance in Staphylococcus aureus. J Antimicrob Chemother 2005; 55(3): 379-382.
9. Lipsky BA, Itani K, Norden C. Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate. Clin Infect Dis 2004; 38(1): 17-24.
10. Senneville E, Legout L, Valette M, Yazdanpanah Y, Bel-trand E, Caillaux M et al. Effectiveness and Tolerability of prolonged linezolid treatment for chronic osteomyelitis: a retrospective study. Clin Ther 2006; 28(8): 1155-1163.
11. Razonable RR, Osmon DR, Steckelberg JM. Linezolid therapy for orthopedic infections. Mayo Clin Proc 2004; 79(9): 1137-1144.
12. Lovering AM, Zhang J, Bannister GC, Lankester BJA, Brown JHM, Narendra G et al. Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement. J Antimicrob Chemother 2002; 50(1): 73-77.
13. Aneziokoro CO, Cannon JP, Pachucki CT, Lentino JR. The effectiveness and safety of oral linezolid for the primary and secondary treatment of osteomyelitis. J Chemother 2005; 17(6): 643-650.
14. Bassetti M, Righi E, Di BA, Rosso R, Beltrame A, Bassetti D. Role of linezolid in the treatment of orthopedic infections. Expert Rev Anti Infect Ther 2005; 3(3): 343-352.
15. Rayner CR, Baddour LM, Birmingham MC, Norden C, Meagher AK, Schentag JJ. Linezolid in the treatment of osteomyelitis: results of compassionate use experience. Infection 2004; 32(1): 8-14.
16. Bassetti M, Di Biagio A, Cenderello G, Del Bono V, Palermo A, Cruciani M et al. Linezolid treatment of prosthetic hip infections due to methicillin-resistant Staphylococcus aureus (MRSA). J Infect 2001; 43(2): 148-149.
17. Rao N, Ziran BH, Hall RA, Santa ER. Successful treatment of chronic bone and joint infections with oral linezolid. Clin Orthop Relat Res 2004; (427): 67-71.
18. Senneville E, Legout L, Valette M, Yazdanpanah Y, Gi-raud F, Beltrand E et al. Risk factors for anaemia in patients on prolonged linezolid therapy for chronic osteomyelitis: a case-control study. J Antimicrob Chemother 2004; 54(4): 798-802.
19. Vercillo M, Patzakis MJ, Holtom P, Zalavras CG. Linezolid in the treatment of implant-related chronic osteomyelitis. Clin Orthop Relat Res 2007; 461: 40-43.
20. Wu VC, Wang YT, Wang CY, Tsai IJ, Wu KD, Hwang JJ et al. High frequency of linezolid-associated thrombocytopenia and anemia among patients with end-stage renal disease. Clin Infect Dis 2006; 42(1): 66-72.
21. Attassi K, Hershberger E, Alam R, Zervos MJ. Thrombocytopenia associated with linezolid therapy. Clin Infect Dis 2002; 34(5): 695-698.
22. Bassetti M, Vitale F, Melica G, Righi E, Di Biagio A, Molfetta L et al. Linezolid in the treatment of gram-positive prosthetic joint infections. J Antimicrob Chemother 2005; 55(3): 387-390.